Dr. Ernest Tambo
My Social Links

Dr. Ernest Tambo

Associate Professor
National Consultant M&E, Development of M&E tools (REMAP, DHIS2 and SIMEX), Cameroon


Highest Degree
Ph.D. in Molecular Pharmacology from University of Ibadan, Nigeria

Share this Profile

Area of Interest:

Pharmacology and Toxicology
100%
Pharmacovigilance
62%
Epidemiology
90%
Drug Delivery
75%
Genotypes
55%

Research Publications in Numbers

Books
1
Chapters
3
Articles
110
Abstracts
41

Selected Publications

  1. Bengyella, L., E.L. Yekwa, K. Nawaz, S. Iftikhar and E. Tambo et al., 2018. Global invasive Cochliobolus species: Cohort of destroyers with implications in food losses and insecurity in the twenty-first century. Arch. Microbial., 200: 119-135.
    Direct Link  |  
  2. Adebamowo, S.N., V. Francis, E. Tambo, S.H. Diallo and G. Landoure et al., 2018. Implementation of genomics research in Africa: Challenges and recommendations. Global Health Action, Vol. 11. /10.1080/16549716.2017.1419033.
    CrossRef  |  Direct Link  |  
  3. Zhou, X., E. Tambo, J. Su, Q. Fang and W. Ruan et al., 2017. Genetic diversity and natural selection in 42 kda region of Plasmodium vivax merozoite surface protein-1 from china-myanmar endemic border. Korean j. Parasitol., 55: 473-480.
    CrossRef  |  Direct Link  |  
  4. Yah, C.S., O. Adeagbo and T. Ernest, 2017. HIV and sexually transmitted co-infections among sex workers in the Southern African economic region. Ann. Trop. Med. Public Health, 10: 1128-1136.
    Direct Link  |  
  5. Yah, C.S., E. Tambo, C. Khayeka-Wandabwa and J.Y. Ngogang, 2017. Impact of telemonitoring approaches on integrated HIV and TB diagnosis and treatment interventions in sub-Saharan Africa: A scoping review. Health promotion perspect., 7: 60-65.
    CrossRef  |  Direct Link  |  
  6. Tambo. E., 2017. Improving disaster risk reduction preparedness and emergency response readiness and resilience in Africa. Intl J. Public Health Sci., 6: 183-191.
  7. Tambo, E., S. Tang, L. Ai and X.N. Zhou, 2017. The value of China-Africa health development initiatives in strengthening “One Health” strategy. Global Health J., 1: 33-46.
  8. Tambo, E., O.A. Olalubi, C.F. Chengho, I. Wurie, J.K. Jonhson, M. Fogang and J.Y. Ngogang, 2017. Ebola outbreaks public health emergencies in fragile conflicts zones and displaced populations in Africa. Int. J. Trop. Dis. Health., 26: 1-15.
    CrossRef  |  Direct Link  |  
  9. Tambo, E., J. Tei-Wu, X. Ning, W. Hu and Z. Xiao-Nong, 2017. Impact evaluation of schistosomiasis control into elimination interventions models in P. R. China and Africa. J. Microbiol. Infect. Dis., 07: 104-117.
    CrossRef  |  Direct Link  |  
  10. Tambo, E., G. Madjou, C. Khayeka-Wandabwa, O.A. Olalubi, C.F. Chengho and E.I.M. Khater, 2017. Ethical, legal and societal considerations on Zika virus epidemics complications in scaling-up prevention and control strategies. Philosophy, Ethics Humanities Med., Vol. 12. 10.1186/s13010-017-0046-8.
    CrossRef  |  Direct Link  |  
  11. Tambo, E., C.F. Chengho, C.E. Ugwu, I. Wurie, J.K. Jonhson and J.Y. Ngogang, 2017. Rebuilding transformation strategies in post-ebola epidemics in Africa. Inf. Dis. poverty, Vol. 6. 10.1186/s40249-017-0278-2.
    CrossRef  |  Direct Link  |  
  12. Tambo, E., C. Khayeka-Wandabwa, O.A. Oluwasogo, A.A. Adedeji, J.Y. Ngogang and E.I.M. Khater, 2017. Addressing knowledge gaps in molecular, sero-surveillance and monitoring approaches on Zika epidemics and other arbovirus co-infections: A structured review. J. Parasite Epidemiol. Control, 2: 50-60.
    CrossRef  |  Direct Link  |  
  13. Tambo, E., A.M. Fouad and E.I. Khater, 2017. Strengthening community emergency preparedness and response in threats and epidemics disasters prevention and management in Saudi Arabia. Int. J. Emergency Manage., 13: 288-303.
    CrossRef  |  Direct Link  |  
  14. Tambo, E., 2017. Toward pragmatic and integrated health policies reforms and transformation in Africa. J. Infect.. Dis. Travel Med., Vol. 1. .
    Direct Link  |  
  15. Tambo, E. and A. Kazienga, 2017. Promoting cybersecurity awareness and resilience approaches, capabilities and actions plans against cybercrimes and frauds in Africa. Int. J. Cyber Secur. Digital Forensics, 6: 126-138.
    CrossRef  |  Direct Link  |  
  16. Olalubi, O.A., A.A. Adio, S.K. Babatunde, H.O. Sawyerr, T. Ajara and E. Tambo, 2017. Response of undergraduates to institutional emergency strategies on Ebola virus disease in Kwara State University, Nigeria. J. Public Behav., 7: 21-28.
  17. Noche, C.D., P.R.F. Kwetche, T. Tumameu, E. Tambo, R. Moyou and A.L. Bella, 2017. Relationship between tropical endemic limbo-conjunctivitis and intestinal helminths in a population of Cameroonian children. Cogent Med., Vol. 4. 10.1080/2331205X.2017.1345587.
    CrossRef  |  Direct Link  |  
  18. Mewabo, A.P., R.S. Moyou, L.E. Kouemeni, J.Y. Ngogang, L. Kaptue and E. Tambo, 2017. Assessing the prevalence of urogenital schistosomaisis and transmission risk factors amongst school-aged children around mape dam ecological suburbs in Malantouen district, Cameroon. Infect. Dis. Poverty, Vol. 6. 10.1186/s40249-017-0257-7.
    CrossRef  |  Direct Link  |  
  19. Marinda, P., N. Chibwe, E. Tambo, S. Lulanga and C. Khayeka-Wandabwa, 2017. Challenges and opportunities of optimal breastfeeding in the context of HIV option B+ guidelines. BMC Public Health, Vol. 17. 10.1186/s12889-017-4457-7.
    CrossRef  |  Direct Link  |  
  20. Djobet, M.N., D. Singhe, J. Lohoue, C. Kuaban, J. Ngogang and E. Tambo, 2017. Antiretroviral therapy supply chain quality control and assurance in improving people living with HIV therapeutic outcomes in Cameroon. AIDS Res. Ther., Vol. 14. 10.1186/s12981-017-0147-x.
    CrossRef  |  Direct Link  |  
  21. Bengyella, L., L.E. Yekwa, S.D. Waikhom, K. Nawaz and S. Iftikhar et al., 2017. Upsurge in curvularia infections and global emerging antifungal drug resistance. Asian J. Scient. Res., 10: 299-307.
    CrossRef  |  Direct Link  |  
  22. Bengyella, L., E.L. Yekwa, M.N. Subhani, E. Tambo and K. Nawaz et al., 2017. Invasive Aspergillus terreus morphological transitions and immunoadaptations mediating antifungal resistance. Infect. Drug Resist., 10: 425-436.
    CrossRef  |  Direct Link  |  
  23. Tambo, E., W. Duo-Quan and X.N. Zhou, 2016. Tackling air pollution and extreme climate changes in China: Implementing the Paris climate change agreement. Environ. Int., 95: 152-156.
    CrossRef  |  Direct Link  |  
  24. Tambo, E., T.A. Anyorigiya, A. Matimba, A.A. Adedeji and J.Y. Ngogang, 2016. Digital pharmacy and pharmacovigilance ecosystem in Africa: Perceptions and opportunities. Eur. J. Pharm. Med. Res., 3: 84-90.
  25. Tambo, E., P.D. Chuisseu, J.Y. Ngogang and E.I. Khater, 2016. Deciphering emerging Zika and dengue viral epidemics: Implications for global maternal-child health burden. J. Infect. Public Health, 9: 240-250.
    CrossRef  |  Direct Link  |  
  26. Tambo, E., O.A. Olalubi and M. Sacko, 2016. Rift valley hemorrhagic fever epidemics in niger cross border with mali, west africa. Lancet. Inf. Dis., 16: 1319-1320.
    CrossRef  |  Direct Link  |  
  27. Tambo, E., J.H. Chen, X.N. Zhou and E.I.M. Khater, 2016. Outwitting dengue threat and epidemics resurgence in Asia-Pacific countries: Strengthening integrated dengue surveillance, monitoring and response systems. Infect. Dis. Poverty, Vol. 5. 10.1186/s40249-016-0148-3.
    CrossRef  |  Direct Link  |  
  28. Tambo, E., G. Madjou, Y. Mbous, O.A. Olalubi, C. Yah, A.A. Adedeji and J.Y. Ngogang, 2016. Digital health implications in health systems in Africa. Eur. J. Pharm. Med. Res., 3: 91-93.
  29. Tambo, E., G. Madjou, C. Khayeka-Wandabwa, E.N. Tekwu and O.A. Olalubi et al., 2016. Can free open access resources strengthen knowledge-based emerging public health priorities, policies and programs in Africa. F1000Research, Vol. 5. 10.12688/f1000research.8662.1.
    CrossRef  |  Direct Link  |  
  30. Tambo, E., G. Madjou and J.Y. Ngogang, 2016. Wearable sensors and healthcare informatics solutions in non-communicable diseases (Ncds) prevention and management in Africa. J. Health Med. Inform., Vol. 7. 10.4172/2157-7420.1000218.
    CrossRef  |  Direct Link  |  
  31. Tambo, E., C.S. Yah, C.E. Ugwu, O.A. Olalubi, I. Wurie, J.K. Jonhson and J.Y. Ngogang, 2016. Fostering prevention and care delivery services capability on HIV pandemic and Ebola outbreak symbiosis in Africa. J. Infect. Dev. Countries, 10: 1-12.
    Direct Link  |  
  32. Tambo, E., C.E. Ugwu, Y. Guan and D. Wei, 2016. China-Africa health development Initiatives: Benefits and implications for shaping innovative and evidence-informed national health policies and programs in sub-Saharan African countries. Int. J. MCH AIDS, 5: 119-123.
    Direct Link  |  
  33. Tambo, E., C. Khayeka-Wandabwa, H.A. Kamal and E.I.M. Khater, 2016. Boosting preparedness and emergency response systems capacity against Zika and other emerging outbreaks in low resource and vulnerable settings. Austin J. Infect. Dis., Vol. 3. .
    Direct Link  |  
  34. Tambo, E., 2016. Strengthening national immunization coverage capacity and effectiveness strategies in vaccine preventable diseases in rural and urban settings in sub-saharan Africa. J Vaccines Vaccin, Vol. 7. 10.4172/2157-7560.1000306.
    CrossRef  |  Direct Link  |  
  35. Wiwanitkit, V., E. Tambo, E.C. Ugwu, J.Y. Ngogang and X.N. Zhou, 2015. Are surveillance response systems enough to effectively combat and contain the Ebola outbreak. Infect. Dis. Poverty, Vol. 4. 10.1186/2049-9957-4-7.
    CrossRef  |  Direct Link  |  
  36. Tambo, E., T. Oljira, O.A. Oluwasogo, E.I.M. Khater and Z. Xiao-Nong, 2015. Averting MERS-Cov emerging threat and epidemics: The importance of community alertness and preparedness policies and programs. J. Prev. Infect. Control, 1: 2-6.
    Direct Link  |  
  37. Tambo, E., E.U. Chidiebere, A.O. Olowasogo, W. Isatta and K.J. Jeannetta, 2015. Values and hopes of Ebola vaccines mass immunization programs and treatments adoption and implementation benefits in Africa. Int. J. Vaccines Vaccine, Vol. 1. .
    Direct Link  |  
  38. Tambo, E., E.I.M. Khater, J.H. Chen, R. Bergquist and X.N. Zhou, 2015. Nobel prize for the artemisinin and ivermectin discoveries: A great boost towards elimination of the global infectious diseases of poverty. Infect. Dis. Poverty, Vol. 4. 10.1186/s40249-015-0091-8.
    CrossRef  |  Direct Link  |  
  39. Matimba, A., R. Woodward, E. Tambo, M. Ramsay, L. Gwanzura and S. Guramatunhu, 2015. Tele-ophthalmology: Opportunities for improving diabetes eye care in resource-and specialist-limited Sub-Saharan African countries. J. Telemed. Telecare., 22: 311-316.
    CrossRef  |  Direct Link  |  
  40. Ernest Tambo., 2015. Understanding the impact of African traditional beliefs, customs and medicinal practices on the Ebola outbreak Crisis in West Africa; J. Med. Med. Sci., 6: 28-32.
  41. Zhou, X., S. Xia, J.L. Huang, E. Tambo, H.X. Zhuge and X.N. Zhou, 2014. Human babesiosis, an emerging tick-borne disease in the people’s republic of China. Parasites vectors, Vol. 7. .
    Direct Link  |  
  42. Xia, Z.G., R.B. Wang, D.Q. Wang, J. Feng and Q. Zheng et al., 2014. China-Africa cooperation initiatives in malaria control and elimination. Adv. Parasitol., 86: 319-337.
  43. Tambo, E., L. Ai, X. Zhou, J.H. Chen and W. Hu et al., 2014. Surveillance-response systems: The key to elimination of tropical diseases. Infect. Dis. Poverty, Vol. 3. 10.1186/2049-9957-3-17.
    CrossRef  |  Direct Link  |  
  44. Tambo, E., E.C. Ugwu and J.Y. Ngogang, 2014. Need of surveillance response systems to combat Ebola outbreaks and other emerging infectious diseases in African countries. Inf. Dis. poverty, Vol. 3. 10.1186/2049-9957-3-29.
    CrossRef  |  Direct Link  |  
  45. Tambo, E., 2014. Non-conventional humanitarian interventions on Ebola outbreak crisis in West Africa: Health, ethics and legal implications. Infect. Dis. Poverty, Vol. 3. 10.1186/2049-9957-3-42.
    CrossRef  |  Direct Link  |  
  46. Tambo, E. and Z. Xiao-Nong, 2014. Acquired immunity and asymptomatic reservoir impact on frontline and airport ebola outbreak syndromic surveillance and response. J. Infect. Dis. Poverty, Vol.3. 10.1186/2049-9957-3-41.
    CrossRef  |  Direct Link  |  
  47. Chen, S.B., C. Ju, J.H. Chen, B. Zheng and F. Huang et al., 2014. Operational research needs toward malaria elimination in China. Adv. Parasitol., 86: 109-133.
  48. Tambo, E., K. Adama, M. Talla, C.F. Chengho and C. Fotsing, 2014. Digital technology and mobile applications impact on zika and ebola epidemics data sharing and emergency response. Health Med. Informat., Vol. 8. 10.4172/2157-7420.1000254.
    CrossRef  |  Direct Link  |  
  49. Tambo, E., A.A. Adedeji, H. Fang, J.C. Hu, Z.S. Sin and L.H. Thang, 2012. Scaling up impact of malaria control programmes: A tale of events in Sub-Saharan Africa and people’s republic of China Inf. Dis. Poverty J., 1 7.
    CrossRef  |  ASCI  |  PubMed  |  Direct Link  |  
  50. Adedeji, A.A., E. Tambo, F.A. Fehintola, M. Akinwunmi, O.A. Tikare, O.I. Mebude and O.E. Jagun, 2010. Protective response to Sulfadoxine-pyrimethamine during intermittent presumptive treatment of malaria in pregnant women in Sagamu, Nigeria. Afr. J. Pharm. Pharmacol., 4: 754-759.
    Direct Link  |  
  51. Sowunmi, G.O., A. Gbotosho, G.O. Adedeji, A.A. Tambo et al., E. Bolaji, 2008. Herpes simplex labialis in children with acute falciparum malaria. Acta trop., 106: 68-71.
  52. Tatfeng, Y.M., J.C. Ihongbe, M. Okodua, E. Oviasogie and J. Isibor et al., 2007. CD4 Count, Viral Load and Parasite Density of HIV Positive Individuals Undergoing Malaria Treatment With Dihydroartemisinin in Benin City, Edo State, Nigeria. J. Vector Borne Dis., 44: 111-115.
    PubMed  |  Direct Link  |  
  53. Sowunmi, A.G.O., C.T. Gbotosho, A.A. Happi. F.A. Adedeji and O.A. Fehintola et al., 2007. The effects of artemether-lumefantrine versus amodiaquine-sulfalene-pyrimethamine on the gametocytes carriage in children. Am. J. Trop. Med., 77: 235-241.
  54. Sowunmi, G.O., A.A.A. Gbotosho, E. Tambo, B.A. Fateye, C.T. Happi and A.O.J. Amoo, 2006. The effects of artemether-lumefantrine versus amodiaquine-sulfalene-pyrimethamine on the hepatomegaly associated with Plasmodium falciparum malaria in children. J. Parasitol. Res., 206: 89-94.
  55. Tambo, E., T.C. Happi, G.O. Gbotosho, O.A. Folarin and O.B. Yussuf et al., 2005. Open randomized study of artesunate‐amodiaquine vs. chloroquine‐pyrimethamine‐sulfadoxine for the treatment of uncomplicated Plasmodium falciparum malaria in Nigerian children. Trop. Med. Int. Health, 10: 1161-1170.
    CrossRef  |  Direct Link  |  
  56. Sowunmi, B.A., A.A. Fateye, F.A. Adedeji and G.O. Fehintola et al., 2005. Predictors of chloroquine or pyrimethamine-sulfadoxine treatment failure in children with acute uncomplicated falciparum malaria. Ann. Trop. Med. Parasitol., 99: 535-544.
  57. Sowunmi, A., F.A. Fehintola, A.A. Adedeji, G.O. Gbotosho and C.O. Falade et al., 2004. Open randomized study of pyrimethamine-sulphadoxine vs. pyrimethamine-sulphadoxine plus probenecid for the treatment of uncomplicated Plasmodium falciparum malaria in children. Trop. Med. Int. Health, 9: 606-614.
    CrossRef  |  Direct Link  |  
  58. Fehintola, F.A., A.A. Adedeji, E. Tambo, B.A. Fateye, T.C. Happi and A. Sowunmi, 2004. Cotrimoxazole in the treatment of falciparum malaria in Nigerian children a controlled clinical trial. Clin. Drug Invest., 24: 149-155.
    Direct Link  |